Drug-Drug Interaction Study: ASP2151 and Ritonavir

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
ASP2151 is an experimental treatment for herpes. HIV infected people are susceptible to contracting other infections because of their compromised immune system. As HIV patients will be taking drugs to treat the virus this study aims to see if ASP2151 would interact with one of the drugs that is commonly prescribed to HIV patients (ritonavir).
Epistemonikos ID: b3d5524cc3ea16c47c5c782f08611d286eb6e192
First added on: May 12, 2024